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Norbormide is a toxicant selective for rats to which it induces a widespread vasoconstriction. 
In a recent paper, we hypothesized a role of ATP-sensitive potassium (KATP) channels in 
norbormide-induced vasoconstriction. The current study was undertaken to verify this 
hypothesis by comparing the effects of norbormide with those of glibenclamide, a known 
KATP channel blocker. The whole-cell patch-clamp method was used to record KATP currents 
in myocytes freshly isolated from the rat and mouse caudal artery and from the rat gastric 
fundus, as well as in insulin-secreting pancreatic beta cells (INS-1 cells). Smooth muscle 
contractile function was assessed on either rat caudal artery rings or gastric fundus strips. 
Molecular modeling and docking simulation to KATP channel proteins were investigated in 
silico. Both norbormide (a racemic mixture of endo and exo isomers) and glibenclamide 
inhibited KATP currents in rat and mouse caudal artery myocytes, as well as in gastric 
fundus smooth muscle cells. In rat INS-1 cells, only glibenclamide blocked KATP channels, 
whereas norbormide was ineffective. The inhibitory effect of norbormide in rat caudal artery 
myocytes was not stereo-specific as both the endo isomers (active as vasoconstrictor) 
and the exo isomers (inactive as vasoconstrictor) had similar inhibitory activity. In rat caudal 
artery rings, norbormide-induced contraction was partially reverted by the KATP channel 
opener pinacidil. Computational approaches indicated the SUR subunit of KATP channels 
as the binding site for norbormide. KATP channel inhibition may play a role in norbormide-
induced vasoconstriction, but does not explain the species selectivity, tissue selectivity, 
and stereoselectivity of its constricting activity. The lack of effect in INS-1 cells suggests a 
potential selectivity of norbormide for smooth muscle KATP channels.
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INTRODUCTION
Norbormide, a selective rat toxicant, induces a lethal effect in rats but has little or no effect in 
non-rat species, including humans, and for this reason, it has been marketed for many years as 
an eco-sustainable pesticide (Roszkowski, 1965). The mechanism/s underlying the toxic effect of 
norbormide in rats is/are not understood, although existing evidence supports the idea that this 
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toxicant induces a marked and irreversible vasoconstriction of 
rat peripheral vessels by targeting a receptor abundantly and/or 
selectively expressed in the rat peripheral artery myocytes (Bova 
et al., 2001). Norbormide contractile effect is endothelium-
independent (Bova et al., 1996) and is restricted to rat vascular 
smooth muscle (Bova et al., 2003). Intriguingly, in rat conduit 
arteries (i.e., aorta), in rat non-vascular muscles, and in all 
muscles from non-rat species, norbormide, at concentrations 
partially overlapping those that induce vasoconstriction in rats, 
shows vasorelaxant properties, attributed to an inhibitory effect 
on CaV1.2 channels (Bova et al., 2003).
From a chemical perspective, norbormide exists as a racemic 
mixture of up to eight stereoisomers, namely, four endo and 
four exo. Among them, only the endo isomers show rat-specific 
vasoconstrictor activity, being lethal to rats (Poos et al., 1966). 
Collectively, these observations indicate that the contractile 
activity of norbormide is not only species- and tissue-selective 
but also stereo-specific, thus suggesting the existence of a highly 
specific target for this compound in rat vessels.
KATP channels are a heterogeneous family of ion channels 
physiologically regulated by the intracellular concentration 
of ATP. They are composed of two subunits: the Kir subunit, 
forming the channel pore, and the SUR subunit, which binds 
ATP and exerts a regulatory role over the Kir subunit (Yokoshiki 
et al., 1998). Various isoforms of Kir and SUR exist and assemble 
in differing partnerships to form tissue-specific KATP channels 
(Shi et al., 2005). In vascular smooth muscle, sarcolemmal 
KATP channels play a pivotal role in the regulation of vessel tone 
and blood pressure. In particular, activation of these channels 
allows K+ efflux from the cytoplasm to the extracellular space 
with a net loss of positive charges. This leads to membrane 
hyperpolarization, CaV1.2 channel closure, cytoplasmic Ca2+ 
concentration decrease, and vasodilation (Ko et al., 2008; 
Foster and Coetzee, 2016). Conversely, KATP channel inhibition 
causes vasoconstriction. Compounds capable of activating 
KATP channels, e.g., pinacidil and cromakalim, are effective 
relaxant agents in vitro and show powerful hypotensive effects 
in vivo (Ashwood et al., 1986; Gollasch et al., 1995). In contrast, 
inhibition of vascular KATP channels contributes to the contractile 
response induced by receptor-coupled vasoconstrictor agents 
(Bonev and Nelson, 1996) regulating vascular tone, especially in 
resistance and coronary arteries (Tinker et al., 2014).
Glibenclamide is a sulfonylurea widely used as an antidiabetic 
agent (Rydén et al., 2014). In pancreatic beta cells, in fact, it 
blocks KATP channels, thus allowing Ca2+ to enter the cytoplasm 
and stimulate insulin secretion that, in turn, reduces blood 
glucose concentration (Ashcroft and Rorsman, 1989). Although 
glibenclamide displays high affinity for the pancreatic KATP 
channel isoform, it also affects KATP channels in other tissues and 
is therefore widely used in vitro as a pharmacological tool.
We have recently demonstrated that a fluorescent derivative of 
endo-norbormide (NRB-AF12) features a subcellular fluorescence 
profile similar to that of ER-Tracker®, a commercially available 
fluorescent derivative of glibenclamide (D’Amore et al., 2016; 
D’Amore et al., 2018; Forgiarini et al., 2019). This phenomenon 
occurred in several cell types, including freshly isolated rat caudal 
artery myocytes, where norbormide behaves as a contracting 
agent. Based on these results, we hypothesized that norbormide 
and glibenclamide can potentially bind to the same cellular target, 
namely, KATP channels, and that these channels can play a role 
in norbormide-induced vasoconstriction. This hypothesis was 
assessed in the present study by: i) studying norbormide effects on 
KATP currents recorded in vascular and non-vascular myocytes, 
as well as in INS-1 beta cells; ii) evaluating its functional activity 
on smooth muscle preparations; and iii) performing an in silico 
analysis to identify its potential binding site in KATP channels. 
In all these experiments, glibenclamide was used as a reference 
KATP inhibitor.
MATERIALS AND METHODS
All animal care and experimental protocols conformed to the 
European Union Guidelines for the Care and Use of Laboratory 
Animals (European Union Directive 2010/63/EU) and had been 
approved by the Italian Department of Health (666/2015-PR, 
650/2015, 41451.N.ZRS/2018).
Vasoconstriction Assay
Two-millimeter-long caudal artery rings were obtained from 
the main (ventral) caudal artery of male Wistar rats (160–230 g, 
Charles River Italia, Calco, Italy) anesthetized by CO2 and killed 
by decapitation.
The rings, cleaned of the adventitia, were mounted by 
inserting two 100-µm-thick tungsten wires into their lumen in 
home-made myographs, as previously described (Bova et al., 
2003). The devices holding the rings were then immersed into 
20-ml double-jacketed organ baths containing a salt solution of 
the following composition (in mM): NaCl 125, KCl 5, MgSO4 
1, KH2PO4 1.2, CaCl2 2.7, NaHCO3 25, and glucose 11, pH 
7.35, bubbled with a mixture of O2 (95%) and CO2 (5%), and 
maintained at 37°C. At the beginning of the experiment, a preload 
of 2 g (1 g/mm) was applied to each ring. The preloaded rings 
were left to equilibrate for at least 60 min and then repeatedly 
stimulated with 90 mM KCl and 10 µM phenylephrine until two 
consecutive reproducible contractile responses to each stimulus 
were obtained. The contractile force was measured through an 
isometric force transducer (2B Instruments, Milan, Italy) coupled 
to an analog-to-digital converter (PowerLab) and was displayed 
on the monitor of a PC. The experiments were conducted in 
rings mechanically deprived of the endothelium; the absence of a 
functional endothelium was confirmed by the lack of carbachol-
induced relaxation of rings precontracted with phenylephrine.
Rat Fundus Assay
Gastric fundus strips were obtained from the stomach of 
male Wistar rats (200–250 g, Charles River Italia, Calco, Italy) 
anesthetized (i.p). with a mixture of Zoletil 100® (7.5 mg/kg 
tiletamine and 7.5 mg/kg zolazepam; Virbac Srl, Milano, Italy) 
and Xilor® (4 mg/kg xylazine; Bayer, Milan, Italy) containing 
heparin (5,000 U/kg), decapitated, and bled. The stomach was 
removed, opened along the longitudinal axis of the greater 
curvature and washed in cold Ca2+-free physiological salt 
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solution (Ca2+-free PSS) containing the following (in mM): NaCl 
118, KCl 4.7, KH2PO4 1.2, MgCl2 1.2, NaHCO3 25, and glucose 
11.5. Smooth muscle strips (1–2 mm in width; 1.5–2 cm in 
length), dissected from the circular layer of the anterior fundus 
wall, were transferred into 25-ml organ bath chambers filled with 
Ca2+-free PSS, pH 7.4, bubbled with O2 (95%) and CO2 (5%) gas 
mixture, and maintained at 37°C. Strips, connected to isometric 
transducers (BLPR, WPI, Berlin, Germany), were stretched to a 
tension of 1 g. After equilibration for 15 min, 2.5 mM Ca2+ was 
added and the strips were allowed to develop stable, spontaneous 
tone over a 30-min period. Afterward, they were challenged 
with two consecutive stimulations with 60 mM K+ (K60), until 
a stable response was obtained. After 45 min of washing in 
PSS, either norbormide or glibenclamide was added and left in 
contact with tissues for 15 min, followed by a K60 stimulation to 
test for muscle functional integrity. Tension was expressed as a 
percentage of the initial response to K60, which was regarded as 
100% (Fusi et al., 1998).
Electrophysiological Experiments
Cell Isolation Procedure From Rat and Mouse 
Tail Main Artery
Rat tail artery myocytes were obtained from the same rats used 
for the fundus assay (see above); mice tail artery myocytes were 
obtained from C57BL6 mice (20–25 g, Internal breeding of the 
Department of Pharmaceutical and Pharmacological Sciences 
of the University of Padua) killed by cervical dislocation. The tail 
artery was cut, cleaned of skin, and placed in external solution 
(containing in mM: 130 NaCl, 5.6 KCl, 10 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 20 glucose, 1.2  MgCl2, 
and 5 Na-pyruvate; pH was adjusted to 7.4 with NaOH). Smooth 
muscle cells were freshly isolated from two mice arteries and a 
5-mm-long piece of rat artery by incubation at 37°C for 40–45 min 
in 2 ml of 0.1 mM Ca2+ external solution containing 20 mM taurine 
(prepared by replacing NaCl with equimolar taurine), 1.25 mg/ml 
collagenase (type XI), 1 mg/ml soybean trypsin inhibitor, and 1 mg/ml 
bovine serum albumin. This solution was gently bubbled with an 
O2 (95%) and CO2 (5%) gas mixture to stir the enzyme solution, as 
previously described (Fusi et al., 2016). Cells were stored in 0.05 mM 
Ca2+ external solution containing 20 mM taurine and 0.5 mg/ml 
bovine serum albumin at 4°C under normal atmosphere, and were 
used within 2 days of isolation (Mugnai et al., 2014).
Cell Isolation Procedure From Rat Gastric Fundus
Gastric smooth muscle cells were freshly isolated from rat gastric 
fundus strips obtained from the same rats used for the fundus 
assay (see above). The strips were digested for 40–45 min at 
37°C in 2 ml of nitrate-rich digestion solution (in mM: NaCl 55, 
NaNO3 65, KCl 5, Na-pyruvate 5, glucose 10, taurine 10, HEPES 
10, and MgCl2 1.2; pH 7.4) containing 2 mg collagenase (type 
I), 2.5 mg bovine serum albumin, and 3 mg soybean trypsin 
inhibitor, bubbled with an O2 (95%) and CO2 (5%) gas mixture 
(Fusi et al., 2001).
Thereafter, cells were mechanically dispersed with a plastic 
pipette in a modified Kraft-bruhe (KB) solution [containing 1 
mg bovine serum albumine and (in mM) NaCl 105, KH2PO4 7, 
KCl 5, glucose 5, taurine 10, HEPES 10, MgCl2 1.6, Na-pyruvate 
2.5, creatine 1.7, oxalacetate 2, Na2ATP 1.5, and ethylene glycol-
bis(2-aminoethylether)-N,N,N´,N´-tetraacetic acid (EGTA) 
0.1; pH adjusted to 7.25 with NaOH] and used for experiments 
within 10 h of isolation. During this time, they were stored at 4°C 
in KB solution containing bovine serum albumin.
INS-1 Cells
INS-1 beta cells (Asfari et al., 1992), kindly provided by Dr. 
Andrea Venerando (Department of Comparative Biomedicine 
and Food Science, University of Padua, Italy), were grown in 
RPMI 1640 medium containing 11.1 mM D-glucose, 1 mM 
sodium pyruvate, 50 μM β-mercaptoethanol, 2 mM glutamine, 
10 mM HEPES, 10% fetal calf serum (FCS), 100 U/ml penicillin, 
100 μg/ml streptomycin, and 250 ng/ml amphotericin B at 
37°C in humidified 5% CO2 and 95% air (Kittl et al., 2016). Cell 
cultures were passaged once a week using the standard trypsin/
EDTA treatment.
Whole-Cell Patch-Clamp Recordings
Cells were continuously superfused with recording solution 
using a peristaltic pump (LKB 2132, Bromma, Sweden) at a flow 
rate of 400 μl/min.
The conventional whole-cell patch-clamp method was 
applied to voltage-clamp smooth muscle cells (Saponara et al., 
2011). Recording electrodes were pulled from borosilicate 
glass capillaries (WPI, Berlin, Germany) and fire-polished to 
obtain a pipette resistance of 2–5 MΩ when filled with internal 
solution.
An Axopatch 200B patch-clamp amplifier (Molecular Devices 
Corporation, Sunnyvale, CA, USA) was used to generate and 
apply voltage pulses to the clamped cells and to record the 
corresponding membrane currents. At the beginning of each 
experiment, the junction potential between the pipette and bath 
solution was electronically adjusted to zero. Current signals, after 
compensation for whole-cell capacitance and series resistance 
(between 70% and 75%), were low-pass filtered at 2 kHz and 
digitized at 3 kHz prior to being stored on the computer hard disk. 
Electrophysiological responses were tested at room temperature 
(20–22°C).
The osmolarity of the external solution and that of the internal 
solution were measured with an osmometer (Osmostat OM 6020, 
Menarini Diagnostics, Florence, Italy) (Fusi et al., 2005).
Analysis of data was accomplished by using pClamp 9.2.1.8 
software (Molecular Devices Corporation).
KATP Current Recording in Tail Artery 
and Gastric Myocytes
Recording solution contained the following (in mM): NaCl 
25, KCl 140, HEPES 10, glucose 10, MgCl2 1, CaCl2 0.1, and 
tetraethylammonium (TEA) 1; pH was adjusted to 7.4 with 
NaOH (320 mosmol). Pipette solution consisted of the following 
(in mM): KCl 140, HEPES 10, EGTA 10, MgCl2 1, glucose 5, 
Na2ATP 0.1, KADP 1, and Na2GTP 0.1; pH was adjusted to 7.3 
with KOH (290 mosmol). To minimize voltage-dependent K+ 
currents, KATP currents were recorded at a steady membrane 
potential (Vh) of −50 mV using a continuous gap-free acquisition 
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protocol. Currents, activated by the KATP channel opener 
pinacidil (10 µM), did not run down during the following 10 min 
under these conditions (data not shown). Care was taken to 
complete each experiment within this period. Current values 
were corrected for leakage using 10 µM glibenclamide, which 
completely blocked KATP currents (Trezza et al., 2018).
Ca2+ is known to stabilize the cell membrane. Due to its 
low concentration in the recording solution, the seal between 
the pipette tip and the cell membrane was frequently lost a 
few minutes after breaking the patch to get the whole-cell 
configuration. Thus, only single concentrations of norbormide 
were assessed in each myocyte. Furthermore, as few cells did not 
respond to pinacidil stimulation, norbormide was always added 
after pinacidil had induced a stable current amplitude.
KATP Current Recording in INS-1 Cells
Recording solution contained the following (in mM): NaCl 140, 
KCl 5.6, CaCl2 2.5, MgCl2 1.5, HEPES 10, D-glucose 4.5, and 
mannitol 5; pH was adjusted to 7.4 with NaOH (300 mosmol). 
Pipette solution contained the following (in mM): potassium 
D-gluconate 120, NaCl 5, KCl 10, CaCl2 2, MgCl2 4, Mg2ATP 
2, HEPES 5, EGTA 10, and raffinose 5; pH was adjusted to 7.2 
with KOH.
KATP currents were recorded by means of an “activator-free” 
protocol, consisting in 500-ms pulses to −80 and −60 mV, 
delivered at 10-s intervals, from a Vh of −70 mV, as previously 
described (Kittl et al., 2016). Under these conditions, currents 
measured were almost entirely KATP currents, as proved by the 
10 µM glibenclamide blockade. The latter was used to correct 
current values for leakage.
Chemicals
Endo- and exo-norbormide isomers were prepared at the 
University of Auckland, New Zealand. Endo-norbormide was 
synthesized as previously described (Brimble et al., 2004). The exo 
isomer was obtained from a solution of endo-norbormide (1.00 g, 
1.95 mmol) in mixed xylenes (20 ml) heated at 140°C for 30 h, 
and the solvent was then removed in vacuo. Purification by flash 
chromatography (petroleum ether/ethyl acetate, 1:1) afforded 
exo-norbormide as a mixture of stereoisomers (R/S/T/X) (beige 
solid; 0.80 g, 1.56 mmol, 80%). 1H NMR (400 MHz, CDCl3) δ 
2.89 (0.15H, dd, J = 7.3, 0.9 Hz, S/H-2), 2.92–2.95 (0.6H, m, T/H-
2, X/H-2), 2.97 (0.25H, dd, J = 7.3, 0.9 Hz, R/H-2), 3.03 (0.45H, 
dd, J = 7.3, 1.1 Hz, X/H-3), 3.06 (0.15H, dd, J = 7.3, 1.1 Hz, S/H-3), 
3.25 (0.15H, dd, J = 7.3, 1.1 Hz, T/H-3), 3.41 (0.25H, dd, J = 7.3, 
1.1 Hz, R/H-3), 3.49–3.50 (0.15H, m, S/H-4), 3.73–3.74 (0.25H, 
m, R/H-1), 3.76–3.77 (0.6H, m, X/H-1, T/H-4), 3.95–3.96 (0.45H, 
m, X/H-4), 4.09–4.10 (0.25H, m, R/H-4), 4.33–4.35 (0.3H, m, 
S/H-1, T/H-1), 5.74–5.76 (0.4H, m, T/H-6, R/H-6), 5.80 (0.15H, 
s, S/OH), 5.86 (0.45H, s, X/OH), 6.15 (0.45H, dd, J = 3.4, 1.1 Hz, 
X/H-6), 6.18 (0.15H, s, T/OH), 6.19 (0.15H, dd, J = 3.4, 1.1 Hz, 
S/H-6), 6.51 (0.25H, s, R/OH), 6.85–7.65 (16H, m, Ar), 8.42–8.59 
(2H, m, αPyr). RP-HPLC: tR = 45.7 (S), 51.7 (T), 58.7 (X), 61.1 (R) 
min (purity λ254nm = >99%). A 1H NMR spectrum and RP-HPLC 
chromatogram are reported in Supplementary Figure 1.
Collagenase (types I and XI), trypsin inhibitor, bovine serum 
albumin, TEA, EGTA, HEPES, taurine, pinacidil, glibenclamide, 
RPMI 1640, β-mercaptoethanol, glutamine, FCS, penicillin, 
streptomycin, and amphotericin B were resourced from Sigma 
Chimica (Milan, Italy). Norbormide (mixed endo and exo 
isomers) was a kind gift from I.N.D.I.A. Industrie Chimiche Srl, 
Padua, Italy. Endo- and exo-norbormide were synthesized at 
the School of Chemical Sciences, University of Auckland, New 
Zealand. Norbormide, pinacidil, and glibenclamide, dissolved 
directly in dimethyl sulfoxide (DMSO), were diluted at least 
1,000 times prior to use. All solutions were stored at −20°C and 
protected from light by wrapping containers with aluminum foil. 
The resulting concentrations of DMSO (below 0.1%, v/v) had no 
influence on tissue or cell responses.
FIGURE 1 | Strucutre of transmembrane KATP channels. Ribbon representation of superimposed Kir6.1 homology model (red) and Kir6.2 cryo-EM structure 6BAA 
(blue) complexed with SUR subunits, SUR2 homology model (orange), and SUR1 cryo-EM structure 6BAA (cyan).
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Statistical Analysis
Individual values, contributing to calculation of the groups’ 
mean  ± SEM values, derived from independent cells, rings, or 
strips that, sometimes, were isolated from the same animal. To 
ensure that mean values are representative of the population, 
however, cells or rings included in the same group were isolated 
from at least three different animals.
Statistical analysis and significance, as measured by either 
repeated measures ANOVA (followed by Dunnett post hoc test) or 
Student’s t test for paired samples (two-tailed), were obtained using 
GraphPad Prism version 5.04 (GraphPad Software Inc., San Diego, 
CA, USA). Post hoc tests were performed only when ANOVA 
found a significant value of F and no variance in homogeneity. In 
all comparisons, P < 0.05 was considered significant.
Homology Model Building and Validation
The cryo-electron microscopy (cryo-EM) structure of the 
pancreatic β-cell KATP channel bound to ATP and glibenclamide, 
with Protein Data Bank identity (PDB) ID 6BAA (Martin et al., 
2017), was used as the main template for the homology model 
(Protein Model Portal; Haas et al., 2013). The UniProt database 
(www.uniprot.org) sequences of Rattus norvegicus KATP channel 
characterized by Kir6.1 Q63664 and Kir6.2 P70673 subunits, 
together with the SUR1 Q09429 and SUR2 Q63563 subunits, 
obtained with ClustalX tool (Jeanmougin et al., 1998), were used 
for alignment. PyMOL plugin PyMod 2.0 (Janson et al., 2017) 
was used to achieve a protein structure prediction by means of 
ClustalO (Sievers et al., 2011). Sequence alignment between R. 
norvegicus Kir6.1 and Kir6.2 exhibited 82% query coverage and 
74% identity with 0.0 E value, while that between R. norvegicus 
SUR1 and SUR2 showed a query coverage of 98% with an identity 
of 72.8% with 0.0 E value.
Based on those alignments, 3D models for target protein 
were generated by using Modeller integrated in Pymod 2.0. 
The quality of the modeled subunits (Kir6.1 and SUR2) was 
assessed using local factors such as packing quality, backbone 
conformation, bond length, and side-chain planarity. Structural 
superimposition between the Kir6.1 and SUR2 model with the 
cryo-EM structure of Kir6.2 and SUR1 (PDB ID 6BAA), as 
reported in Figure 1, showed a high structural similarity with 
backbone root-mean-square distance (RMSD) values of 0.57 
and 1 Å, respectively. Structure validation indicated that the 
protein homology models of subunits Kir6.1 and SUR2 possessed 
reasonable 3D structure with a good stereochemical quality of 
98.8% and 97% of the amino acid residues in the most favored 
regions, respectively, as assessed by Ramachandran plot. Energy 
minimization protocol in the simple point charge water model 
and the RMSD were computed for the KATP channel Kir6.1/SUR2 
three-dimensional model by using GROMACS 2016.4 software 
package (Abraham et al., 2015).
Molecular Docking
The molecular structure of norbormide (10468605 ChemSpider 
ID) was acquired through ChemSpider in Mol format (www.
chemspider.com). The norbormide and glibenclamide pdbqt 
format was generated by using Open Babel tools, adding 
Gasteiger charge (O’Boyle et al., 2011), whereas the pdbqt format 
of the proteins was generated using utility scripts included in 
the AutoDock tools graphical user interface. Norbormide was 
subjected to the steepest descent minimization (500 steps at 
0.02-Å step size) to remove unfavorable clashes, followed by 
100 steps of conjugate gradient minimization (0.02-Å step size; 
Pettersen et al., 2004). Docking simulation studies of ligands 
against the Kir6.1/SUR2 model and the Kir6.2/SUR1 cryo-EM 
structure (Martin et al., 2017) were performed using the flexible 
side-chain protocol based on Iterated Local Search Global 
Optimizer Algorithm of AutoDock/VinaXB (Koebel et al., 2016). 
Protein–ligand network interaction was evaluated with protein–
ligand interaction profiler (PLIP) (Salentin et al., 2015). PyMOL 
1.7.6.0 was used as the molecular graphics system (The PyMOL 
Molecular Graphics System, Version 1.8; Schrödinger, LLC, New 
York, NY, USA).
RESULTS
Effects of Norbormide on KATP Currents in 
Vascular and Non-Vascular Single Cells
The effect of norbormide on KATP channels was assessed in vascular 
(myocytes freshly isolated from rat and mouse tail main artery) 
and non-vascular (myocytes freshly isolated from rat gastric 
fundus) single cells and single INS-1 cells. To limit activation 
of KV and KCa1.1 channels in the vascular and gastric myocytes, 
KATP currents were induced at a Vh of −50 mV in the presence of 
0.1 mM ATP and 1 mM ADP in the pipette solution, and 1 mM 
TEA in the recording solution. In rat vascular myocytes, the KATP 
channel opener pinacidil (10 µM) activated an inward current 
that was significantly antagonized by the KATP channel blocker 
glibenclamide (10 µM; Figure 2A and B). Racemic norbormide 
(5 and 50 µM) inhibited, in a concentration-dependent manner, 
glibenclamide-sensitive currents recorded in the presence of 
pinacidil (Figure 2C and D). Of interest, we found that exo-
norbormide (50 µM) and endo-norbormide (50 µM) had an 
inhibitory efficacy that was comparable to that of norbormide 
(50 µM) (Figure 3A and B). Norbormide (50 µM) also caused 
a significant reduction of KATP current in mice vascular (Figure 
3C) and in rat gastric fundus myocytes (Figure 3D), similarly to 
that observed in rat vascular myocytes.
In direct contrast, norbormide (50 µM) did not affect KATP 
current recorded in INS-1 cells, which was significantly inhibited 
by glibenclamide (10 µM; Figure 4).
Effect of Norbormide and Glibenclamide 
on the Mechanical Activity of Rat Caudal 
Artery Rings and Fundus Strips
These experiments were undertaken to assess and compare the 
mechanical effects of norbormide and glibenclamide on rat 
caudal artery and fundus preparations.
In vascular rings, norbormide, at the same concentration 
(50 µM) that almost completely blocked KATP channels in rat 
caudal artery myocytes, produced a contractile response that 
was 140% of that induced by 90 mM KCl (Figure 5A and B). 
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Norbormide-induced contraction was not affected by the same 
concentration of pinacidil (10 µM) used to activate KATP channels 
in patch-clamp experiments. However, when norbormide 
concentration was lowered to 5 µM, the addition of pinacidil 
indeed caused a 20% relaxation of the active tone (Figure 5C). 
Glibenclamide, up to 200 µM, did not modify basal tension in rat 
caudal artery rings (Figure 5D).
Fifty micromolar NRB-induced vasoconstriction was reverted 
upon washout in about 90 min (data not shown). Furthermore, 
the following addition of 10 µM phenylephrine or 90 mM KCl 
elicited contractile responses comparable to those recorded 
before NRB challenging (data not shown).
Both norbormide (50 µM) and glibenclamide (up to 100 µM) 
were unable to contract rat gastric fundus strips (Figure 5E and F). 
FIGURE 2 | Effect of norbormide on KATP currents of isolated rat tail artery myocytes. (A) Representative whole-cell recordings of inward currents elicited by 10 µM 
pinacidil at a Vh of −50 mV. The effect of 5 µM norbormide as well as of 10 µM glibenclamide is shown. (B) Pinacidil (10 µM) activated glibenclamide-sensitive KATP 
currents, which were inhibited by either (C) 5 µM or (D) 50 µM norbormide. Columns are mean ± SEM (n = 5–7). *P < 0.05, **P < 0.01, ***P < 0.001, Student’s t test 
for paired samples.
FIGURE 3 | Effect of norbormide on KATP currents of isolated rat and mouse tail artery or rat fundus myocytes. (A and B) Pinacidil (10 µM) activated glibenclamide-
sensitive rat tail artery myocytes KATP currents, which were inhibited by either (A) 50 µM exo-norbormide (NRB) or (B) 50 µM endo NRB. (C and D) Pinacidil (10 µM) 
activated glibenclamide-sensitive (C) mouse tail artery and (D) rat gastric fundus myocytes KATP currents, which were inhibited by 50 µM NRB. Columns are mean ± 
SEM (n = 4–5). *P < 0.05, **P < 0.01, Student’s t test for paired samples.
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FIGURE 5 | Effects of norbormide and glibenclamide on the resting tone of rat caudal artery rings and gastric fundus strips. (A–D) Rat caudal artery rings. 
(A) Original recording showing the contractile effect of a maximal concentration of norbormide (50 µM). The addition of 10 µM pinacidil did not affect active muscle 
tone (compared to panel B). (B) Control experiment, performed in parallel with that represented in (A), showing that norbormide-induced contraction spontaneously 
relaxes after the plateau phase, thus suggesting that the relaxation observed in (A) is not pinacidil-dependent. (C) Original recording showing the contractile effect 
of a low concentration of norbormide (5 µM). The addition of 10 µM pinacidil caused a partial relaxation of the active muscle tone. Inset: effect of pinacidil on 
rat caudal rings precontracted with 5 µM norbormide. On the ordinate scale, contraction is reported in g (n = 6; *P < 0.05, Student’s t test for paired samples). 
(D) Glibenclamide, up to 200 µM, was unable to affect ring resting tone. (A–D) The contraction induced by 90 mM KCl and/or 10 µM phenylephrine is also 
shown. Neither (E) glibenclamide nor (F) norbormide contracted rat gastric fundus strips. The effect of 60 mM KCl is also shown. Traces are representative of five 
(norbormide) or six (glibenclamide) similar experiments.
FIGURE 4 | Effect of norbormide on KATP currents of INS-1 cell. KATP currents were recorded at a Vh of −70 mV during 500-ms pulses to −60 mV (white columns) 
and −80 mV (black columns) in the absence (control) or presence of 50 µM norbormide (NRB) as well as NRB plus 10 µM glibenclamide (glib). Columns are mean 
± SEM (n = 7). Insets: average traces of original KATP currents, recorded from seven cells, during 500-ms pulses to −60 mV (left) or −80 mV (glib) in the absence 
(control) or presence of NRB as well as NRB plus glibenclamide. P < 0.001, ANOVA and Dunnett post test.
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The subsequent addition of 60 mM KCl, however, elicited a 
contraction that measured 67.2 ± 10.8% (n = 5) and 90.5 ± 3.5% 
(n = 6) of that recorded in the absence of the drug, respectively.
Molecular Modeling and Docking 
Simulation
The predicted KATP 3D model was comparable to the 6BAA 
template (Martin et al., 2017). Norbormide (both endo and exo 
conformation) was found to be flexible and free to bind the two 
KATP channels, namely, Kir6.1/SUR2 in smooth muscle cells and 
Kir6.2/SUR1 in INS-1 cells. Following docking simulation, the 
best predicted binding interaction of norbormide (Figure 6A) and 
glibenclamide (Figure 6B) with the Kir6.1/SUR2 channel showed 
comparable thermodynamic affinities (−9.2 and −8.7 kcal/mol, 
respectively), while those towards the Kir6.2/SUR1 channel were 
different (−6.7 and −8.9 kcal/mol; Figure 6C and D). Protein–
ligand interaction profiler (PLIP) tool results showed interaction 
network profiles with remarkable differences in the number and 
bond typologies, as reported in Figure 6 and Table 1.
Structural analysis of SUR2–norbormide complex binding 
pocket residues revealed hydrophobic interactions, π-cationic, 
π-stacking, and hydrogen bonds, whereas, in the case of 
the SUR1–norbormide complex, the different amino acid 
composition prevented analogous interactions, as shown in 
Figure 7. In contrast, glibenclamide formed bonds, similar per 
number and typologies, with both SUR subunits, as shown in 
Figure 6 and Table 1.
DISCUSSION
A key finding of this study is that norbormide inhibits KATP 
current in myocytes freshly isolated from the rat caudal artery. 
This effect was concentration-dependent and was observed at 
norbormide concentrations overlapping those eliciting a slowly 
reversible, contractile effect in the rat caudal artery rings (see also 
Bova et al., 1996).
Pinacidil-induced KATP current was only partially antagonized 
by 5 µM norbormide and almost completely blocked by 10 times 
FIGURE 6 | Glibenclamide and norbormide binding site. (A and B) Inhibited SUR2 cartoon structure (PDB accession number 6BAA) showing only the interactions 
between residues’ binding site (cyan sticks) and (A) glibenclamide (purple sticks) or (B) norbormide (blue sticks). (C and D) SUR1 cartoon model structure, showing 
only the interactions between residues’ binding site (orange sticks) and (C) glibenclamide (purple sticks) or (D) norbormide (blue sticks).
TABLE 1 | Glibenclamide– and norbormide–SUR subunit complex interaction network.
Hydrophobic interaction H-bond π-stacking π-cation
GLB–SUR1 Ile-381, Trp-430, Thr-588, Leu-592 Tyr-377
Thr-1242
Arg-1246
NRB–SUR1 Tyr-377, Ile-381, Trp-430, Leu-434 Arg-1300
GLB–SUR2 Tyr-370, Thr-373, Trp-423, Phe-426, Thr-580, Phe-591, Tyr-1205, Leu-1208 Arg-304
Arg-1213
NRB–SUR2 Tyr-347, Leu-427, Leu-584, Thr-587, Phe-591 Thr-373
R-1240
Trp-423
Tyr-1205
Arg-1240
Residues engaged in different types of binding interactions were calculated by PLIP tool. NRB: ENDO- and ESO-norbormide.
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higher concentrations of the compound. Accordingly, pinacidil 
failed to counteract the contraction induced by 50 µM norbormide 
and partly reverted that elicited by a 10 times lower concentration of 
the compound. Though these data point to KATP channel blockade as 
the mechanism underlying norbormide-induced vasoconstriction, 
other observations presented in this study suggest that this activity 
is only partially responsible for norbormide vasotonic effect 
and that there are likely other mechanisms involved. In fact, 
norbormide-induced KATP current inhibition could be observed 
not only with endo-specific norbormide (vasoactive), but also with 
exo-specific norbormide, known to be inactive as a vasoconstrictor 
and non-toxic to rats (Poos et al., 1966). Furthermore, KATP current 
inhibition could also be demonstrated in myocytes freshly isolated 
from mouse caudal artery and from rat stomach, i.e., from smooth 
muscles that are not contracted, but rather relaxed, by norbormide 
(Bova et al., 2003). Taken together, these findings indicate that the 
norbormide-induced block of KATP channels is not sufficient to 
trigger the contractile process.
Glibenclamide inhibited KATP current in all the smooth muscle 
cells investigated, though it was unable to induce contraction in 
the corresponding whole tissues, i.e., rat caudal artery rings and 
fundus strips, even at concentrations much higher than those 
required to block KATP current. However, not all the arteries are 
insensitive to glibenclamide: several reports show that this drug 
causes constriction of coronary arteries in various animal species, 
including rat (Bril et al., 1992; Imamura et al., 1992; Jackson et al., 
1993). In this regard, it is worth noting that norbormide is also 
endowed with a strong coronaro-constrictor activity, which is 
observed only in rats (Roszkowski, 1965).
On the one hand, the results of the present study suggest that 
glibenclamide and norbormide share several functional and 
electrophysiological properties in vascular and non-vascular 
smooth muscles. Previous studies also revealed other similarities 
between the two drugs, i.e., activation of the mitochondrial 
permeability transition pore (Ricchelli et al., 2005; Skalska et al., 
2005; Zulian et al., 2011) and inhibition of CaV1.2 channels 
(Bian and Hermsmeyer, 1994; Fusi et al., 2002). The latter is 
fascinating since it apparently contrasts to the blockade of KATP 
channels (usually causing membrane potential to depolarize and 
CaV1.2 channels to open) and the corresponding vasoconstrictor 
activity. On the other hand, norbormide and glibenclamide differ, 
as the former did not affect KATP channel currents of INS-1 cells. 
This observation suggests a possible selectivity of norbormide 
towards smooth muscle KATP channels and indicates that channel 
inhibition operated by norbormide and glibenclamide is driven 
by a different mechanism of action. This hypothesis is further 
supported by the docking results.
The structural analysis of the protein–ligand complex was 
initially focused on a sequence-conserved, cytoplasmic, physical 
gate site called G loop (Hibino et al., 2010) that plays a crucial 
role in the regulation of KATP gating kinetics (Shimomura et al., 
2009; Li et al., 2016; Lu et al., 2016). Docking simulation of 
norbormide against either Kir6.1 or Kir6.2 G loop revealed that 
the compound was unable to dock these binding pockets, owing 
to its steric hindrance. Instead, a blind docking simulation 
indicated that norbormide bound KATP channel in the same 
pocket of glibenclamide (Martin et al., 2017), though with 
different interaction profiles and binding energy affinities, which 
seem to be crucial for their different mechanism of action.
Blockade of KATP channels, mediated by PKC activation, 
characterizes the activity of several vasoconstrictors (Bonev and 
Nelson, 1996; Liu and Khalil, 2018). Noticeably, norbormide-
induced contraction of rat caudal artery is accompanied by the 
activation of the PLC–PKC pathway (Bova et al., 2001). However, 
FIGURE 7 | Sequence alignment results between R. norvegicus SUR2 and the template sequence of R. norvegicus SUR1. Identical and positively conserved amino 
acids (marked with a star and colon, respectively) are highlighted in colors according to the property of the corresponding query residue in the alignment. Green arrows 
highlight all the amino acids involved in glibenclamide and norbormide binding regions. Red arrows: non-conserved amino acids engaged in interaction network.
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neither mouse caudal artery nor rat vascular and gastric smooth 
muscle was contracted by exo-specific norbormide, although it 
is capable to block KATP channels. Therefore, the involvement of 
PKC in KATP channel current inhibition operated by norbormide 
and its isomers can be ruled out.
In conclusion, the selective rat toxicant norbormide is 
a KATP channel blocker likely exerting a direct effect on the 
channel protein. This activity can, at least in part, underline the 
vasoconstrictor effect observed in the rat tail artery. In addition, 
the lack of effect of norbormide on KATP channels in INS-1 cells 
may suggest a potential selectivity of this compound towards 
smooth muscle cell channels.
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